CBARP and cancer: In the accompanying article (Creixell et al., 2015), we utilize the bona fide DoS described here to identify cancer mutations perturbing them and experimentally validate their role in causing signaling rewiring (Creixell et al., 2012) and thus contributing to oncogenesis by affecting kinase specificity.